RICERCA ITALIANA     

Programmi di ricerca simili:

• 1 - Studio dei meccanismi di citotossicità e genotossicità di nanoparticelle di silice e silicati fibrosi nanometrici con dimensioni, struttura e composizione strettamente controllate.
• 2 - RISCHI DELL'ESPOSIZIONE A MATERIALI NANOSTRUTTURATI: STUDI CHIMICO-FISICI E DI TOSSICITA' SU MODELLI IN VIVO E IN VITRO PER LA CARATTERIZZAZIONE DEI MECCANISMI FISIOPATOLOGICI E DEL PROFILO CINETICO DELLE PARTICELLE.
• 3 - COMPLICANZE OSTETRICHE DA ANTICORPI ANTI-FOSFOLIPIDI: meccanismi patogenetici molecolari quali nuovi target terapeutici e marcatori prognostici.
• 4 - Medulloblastoma: studio delle vie molecolari di sviluppo e progressione tumorale allo scopo di identificare approcci terapeutici innovativi
• 5 - Effetti molecolari di interferenti endocrini e loro abbattimento mediante tecnologie innovative
• 6 - La cardiotossicità da terapia anti-neoplastica coinvolge le cellule staminali e progenitori miocardici residenti
• 7 - Ruolo di TRAIL nella fisiopatologia emopoietica e vascolare
• 8 - Isolamento e caratterizzazione molecolare e funzionale delle cellule staminali leucemiche (LSCs) per lo sviluppo di nuove strategie terapeutiche.
• 9 - Modulazione dei meccanismi di apoptosi in corso di risposta immunitaria/infiammatoria: studio delle interazioni tra citochine della famiglia del TNF per la caratterizzazione di meccanismi molecolari e cellulari funzionali alla identificazione di nuovi target per la terapia di malattie croniche degenerative.
• 10 - STRATEGIE FARMACOLOGICHE E NUTRIZIONALI PER LA PREVENZIONE DI PATOLOGIE CRONICO-DEGENERATIVE CON ISOTIOCIANATI DA CRUCIFERE

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze mediche
  • PATOLOGIA GENERALE
  • MEDICINA INTERNA
  • MEDICINA DEL LAVORO
• Area scientifico disciplinare: Scienze biologiche
  • GENETICA

Classificazione brevettuale

• CHEMISTRY; METALLURGY
  • BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY (installation for fermenting manure A01C3/02; preservation of living parts of humans or animals A01N1/02; physical or chemical apparatus in general B01; malting or mashing apparatus C12C1/00; brewing apparatus C12C13/00; fermentation apparatus for wine C12G; apparatus for preparing vinegar C12J1/10)
    • MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF (biocides, pest repellants or attractants, or plant growth regulators, containing micro-organisms, viruses, microbial fungi, enzymes, fermentates or substances produced by or extracted from micro-organisms or animal material A01N63/00; food compositions A21, A23; medicinal preparations A61K; chemical aspects of, or use of materials for, bandages, dressings, absorbent pads or surgical articles A61L; fertilisers C05); PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS (preservation of living parts of humans or animals A01N1/02); MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (micro-biological testing media C12Q)
  • INORGANIC CHEMISTRY (processing powders of inorganic compounds preparatory to the manufacturing of ceramic products C04B35/00; fermentation or enzyme-using processes for the preparation of elements or inorganic compounds except carbon dioxide C12P3/00; obtaining metal compounds from mixtures, e.g. ores, which are intermediate compounds in a metallurgical process for obtaining a free metal C21B, C22B; production of non-metallic elements or inorganic compounds by electrolysis or electrophoresis C25B)
    • COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F (metal hydrides [N: monoborane, diborane or addition complexes thereof] C01B6/00; salts of oxyacids of halogens C01B11/00; peroxides, salts or peroxyacids C01B15/00; thiosulfates, dithionites, polythionates C01B17/64; compounds containing selenium, or tellurium C01B19/00; binary compounds of nitrogen with metals C01B21/06; azides C01B21/08; [N: compounds containing nitrogen, other non-metals and metal C01B21/082]; metal amides C01B21/092; nitrites C01B21/50; [N: compounds of noble gases C01B23/00B]; phosphides C01B25/08; salts of oxyacids of phosphoru C01B25/16; carbides C01B31/30; compounds containing silicon C01B33/00; compounds containing boron C01B35/00; compounds having molecular sieve properties but not having base-exchange properties C01B37/00; compounds having molecular sieve and base-exchange properties, e.g. crystalline zeolites, C01B39/00; cyanides C01C3/08; salts of cyanamide C01C3/16; thiocyanates C01C3/20) [C9602]

Classificazione geografica

• Regione: Emilia Romagna

Bibliografia

[1] Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science 2006;311: 622-627.
[2] Colvin VL. The potential environmental impact of engineered nanomaterials. Nat Biotechnol 2006;21:1166-1170.
[3] Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005;113:823-839.
[4] Mills NL, Tornqvist H, Robinson SD, et al. Diesel exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysis. Circulation 2005;112:3930-3936.
[5] Donaldson K, Tran L, Jimenez LA, Duffin R, Newby DE, Mills N, MacNee W, Stone V. Combustion-derived nanoparticles: a review of their toxicology following inhalation exposure. Part Fibre Toxicol 2005;21:210-224.
[6] Nemmar A, Vanbilloen H, Hoylaerts MF, Hoet PH, Verbruggen A, Nemery B. Passage of intratracheally instilled ultrafine particles from the lung into the systemic circulation in hamster. Am J Resp Critical Care Med 2001;164:1665-1668.
[7] Donaldson K, Tran CL. Inflammation caused by particles and fibers. Inhal Toxicol 2002;14:5-27.
[8] Tao F, Gonzalez-Flecha B, Kobzik L. Reactive oxygen species in pulmonary inflammation by ambient particulates. Free Radic Biol Med 2003;35:327-340.
[9] Gold DR, Litonjua A, Schwartz J, et al. Ambient pollution and heart rate variability. Circulation 2000;101:1267-1273.
[10] Liao D, Creason J, Shy C, Williams R, Watts R, Zweidinger R: Daily variation of particulate air pollution and poor cardiac autonomic control in the elderly. Environ Health Perspect 1999;107:521-525.
[11] Brook RD, Franklin B, Cascio W, et al. Air Pollution and Cardiovascular Disease. A Statement for Healthcare Professionals From the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation 2004;109:2655-2671.
[12] Bottini M, Balasubramanian C, Dawson MI, Bergamaschi A, Bellucci S, Mustelin T. Isolation and characterization of fluorescent nanoparticles from pristine and oxidized electric arc-produced single-walled carbon nanotubes. J. Phys. Chem. B 2006;110:831.
[13] Donaldson K, Aitken R, Tran L, Stone V, Duffin R, Forrest G, Alexander A. Carbon Nanotubes: a Review of Their Properties in Relation to Pulmonary Toxicology and Workplace Safety. Toxicol Sci. 2006 Feb 16; [Epub ahead of print]
[14] Cai H, Cao X, Jiang Y, He P, Fang Y. Carbon nanotube-enhanced electrochemical DNA biosensor for DNA hybridization detection. Anal Bioanal Chem. 2003;375:287-293.
[15] Wang S, Humphreys ES, Chung SY, et al. Peptides with selective affinity for carbon nanotubes. Nat Mater. 2003;2:196-200.
[16] Okamoto H, Nakanishi T, Nagai Y, Kasahara M, Takeda K. Variety of the molecular conformation in Peptide nanorings and nanotubes. J Am Chem Soc 2003;125:2756-2769.
[17] Supronowicz PR, Ajayan PM, Ullmann KR, Arulanandam BP, Metzger DW, Bizios R. Novel current-conducting composite substrates for exposing osteoblasts to alternating current stimulation. J Biomed Mater Res 2002;59:499-506.
[18] Sotiropoulou S, Chaniotakis NA. Carbon nanotube array-based biosensor. Anal Bioanal Chem 2003; 375:103-105.
[19] Georgakilas V, Tagmatarchis N, Pantarotto D, Bianco A, Briand JP, Prato M. Amino acid functionalisation of water soluble carbon nanotubes. Chem Commun (Camb). 2002; 21:3050-3051.
[20] Cui D, Tian F, Ozkan CS, Wang M, Gao H. Effect of single wall carbon nanotubes on human HEK293 cell. Toxicol Lett 2005;155:73-85.
[21] Monteiro-Riviere NA, Nemanich RJ, Inman AO, Wang YY, Riviere JE. Multi-walled carbon nanotube interactions with human epidermal keratinocytes. Toxicol Lett 2005;155:377-384.
[22] Bottini M, Bruckner S, Nika K, Bottini N, Bellucci S, Magrini A, Bergamaschi A, Mustelin T. Multi-walled carbon nanotubes induce T lymphocyte apoptosis. Toxicol Lett 2006;160:121-126.
[23] Warheit DB, Laurence BR, Reed KL, Roach DH, Reynolds GA, Webb TR. Comparative pulmonary toxicity assessment of single walled carbon nanotubes in rats. Toxicol Sci 2004;77:117-125.
[24] Shvedova AA, Kisin ER, Mercer R, et al. Unusual inflammatory and fibrogenic pulmonary response to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol 2005;289:L698-L708.
[25] Manna SK, Sarkar S, Barr J, et al. Single-walled carbon nanotube induces oxidative stress and activates nuclear transcription factor kappaB in human keratinocytes. NanoLett 2005;5:1676-1684.
[26] Shedova AA, Castranova V, Kisin ER, et al. Exposure to carbon nanotube material: assessment of nanotube cytotoxicity using human keratinocyte cells. J Toxicol Environ Health 2003;66:1909-1926.
[27] Kreilgaard M.Influence of microemulsions on cutaneous drug delivery. Adv Drug Deliv Rev 2002;54 S77-S98.
[28] Migliore L, Frenzilli G, Nesti C, Fortaner S, Sabbioni E. Cytogenetic and oxidative damage induced in human lymphocytes by platinum, rhodium and palladium compounds. 1: Mutagenesis 2002;17: 411-417.
[29] Stohs SJ and Bagchi D. Oxidative mechanisms in the toxicity of metal-ions, Free Rad. Biol Med 1995;18:321–336.
[30] Leonard SS, Harris GK, Shi XL. Metal-induced oxidative stress and signal transduction. Free Rad Biol Med 2004;37:1921-1942.
[31] Valko M, Morris H, Cronin MTD. Metals, toxicity and oxidative stress. Curr Med Chem 2005;12:1161–1208.
[32] Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicology in Vitro. 2005;19:975-983.
[33] Di Giampaolo L, Di Gioacchino M, Ponti J, et al. "In vitro" comparative immune effects of different titanium compounds. Int J Immunopathol Pharmacol 2006;17:2(S):115-122.
[34] Boscolo P, Carmignani M, Di Gioacchino M, et al. Comparative in vitro study on effects of platinum, palladium and rhodium salts on lymphocyte proliferation and cytokine release. Ann Clin Lab Sci 2004;34:299-306.
[35] Di Gioacchino M, Di Giampaolo L, Verna M, et al. "in vitro" effects of high and low doses of Platinum compounds on lymphocyte proliferation and cytokine release. Ann Clin Lab Sci 2004;34:195-202.
[36] Geiser M, Rothen-Rutishauser B, Kapp N, et al. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect 2005;113:1555-1560.
[37] Mills NL, Amin N, Robinson SD, et al. Do inhaled carbon nanoparticles translocate directly into the circulation of humans? Am J Crit Care Med 2006; 173:426-431.
[38] Kreyling W, Semmler M, Erbe F, Mayer P, Schulz H, Oberdörster G, Ziesenis A. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health A 2002;65:1513-1530.
[39] Oberdörster G, Sharp Z, Atudorei V, et al. Extrapulmonary translocation of ultrafine carbon particle following whole-body inhalation exposure of rats. J Toxicol Environ Health A 2002;65:1531-1543.
[40] Kato T, Yashiro T, Murata Y, et al. Evidence that exogenous substances can be phagocytized by alveolar epithelial cells and transported into blood capillaries. Acc Chem Res 2003;311:47-51.
[41] Nemmar A, Hoylaerts MF, Hoet PH, et al. Ultrafine particles affect experimental thrombosis in an in vivo hamster model. Am J Respir Crit Care Med 2002;166:998-1004.
[42] Nemmar A, Hoylaerts MF, Hoet PH, Vermylen J, Nemery B. Size effect of intratracheally instilled particles on pulmonary inflammation and vascular thrombosis. Toxicol Appl Pharmacol 2003;186:38-45.

Parole Chiave

NANOPARTICELLE, NANOTUBI DI CARBONIO, MODULAZIONE REDOX, MODULAZIONE RISPOSTA INFIAMMATORIA, PERMEABILITA' TRANSEPITELIALE, GENOTOSSICITA', NANOPARTICELLE DI ELEMENTI METALLICI, CELLULE STAMINALI, SISTEMA NERVOSO AUTONOMO